MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
DexCom EV - Enterprise Value 2011-2025 | DXCM
Annual EV - Enterprise Value DexCom
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.4 B | 44.7 B | 53.8 B | 36.5 B | 22.8 B | 12.8 B | 5.16 B | 6.59 B | 5.67 B | 4.47 B | 2.79 B | 1.06 B | 735 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 53.8 B | 735 M | 19.2 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
223 M | $ 17.27 | 1.8 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 15.82 | 0.44 % | $ 170 M |  China |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
35.7 M | $ 1.55 | -4.63 % | $ 1.97 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
DarioHealth Corp.
DRIO
|
6.61 M | $ 12.14 | 2.1 % | $ 344 M | Israel |
 |
Castle Biosciences
CSTL
|
665 M | $ 39.06 | 1.11 % | $ 1.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Exact Sciences Corporation
EXAS
|
12.2 B | $ 101.64 | 0.14 % | $ 18.8 B | USA |
 |
Danaher Corporation
DHR
|
150 B | $ 227.72 | 0.54 % | $ 166 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 27.0 | -0.52 % | $ 816 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
644 M | $ 19.98 | -2.82 % | $ 1.07 B | USA |
 |
Celcuity
CELC
|
506 M | $ 101.67 | -3.4 % | $ 4.01 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
1.5 M | $ 3.3 | -7.82 % | $ 105 K | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 0.29 | -14.47 % | $ 8.51 M | USA |
 |
IQVIA Holdings
IQV
|
54.8 B | $ 222.75 | 0.24 % | $ 40.4 B | USA |
 |
Guardant Health
GH
|
6.94 B | $ 103.7 | 1.6 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
15.3 B | $ 134.4 | -0.35 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
12.4 B | $ 197.62 | 2.4 % | $ 10.2 B | USA |
 |
Quotient Limited
QTNT
|
393 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Mettler-Toledo International
MTD
|
33.2 B | $ 1 410.02 | 1.15 % | $ 29.9 B | Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 183.96 | 0.79 % | $ 20.4 B | USA |
 |
NeoGenomics
NEO
|
1.9 B | $ 12.03 | 1.48 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 6.85 | -0.22 % | $ 1.49 B | USA |
|
Biodesix
BDSX
|
142 M | $ 7.63 | -2.8 % | $ 989 M | USA |
 |
Myriad Genetics
MYGN
|
1.2 B | $ 7.04 | -2.36 % | $ 638 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 262.89 | -0.48 % | $ 22.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 184.38 | -1.18 % | $ 15.2 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
39.1 B | $ 698.77 | -0.77 % | $ 57.6 B | USA |
 |
Lantheus Holdings
LNTH
|
6.44 B | $ 66.4 | -0.33 % | $ 4.59 B | USA |
 |
Agilent Technologies
A
|
45.8 B | $ 140.3 | 0.46 % | $ 42.7 B | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.48 | -2.65 % | $ 5.7 M | USA |
 |
Bioventus
BVS
|
904 M | $ 7.49 | -0.86 % | $ 469 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
2.28 B | $ 2.13 | 0.24 % | $ 540 M | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |